4.8 Article

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

期刊

NUCLEIC ACIDS RESEARCH
卷 50, 期 W1, 页码 W739-W743

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkac382

关键词

-

资金

  1. Academy of Finland [326238, 340141, 345803, 344698]
  2. European Union's Horizon 2020 Research and Innovation Programme [ERA PerMed JAKSTAT-TARGET project]
  3. Cancer Society of Finland
  4. Sigrid Juselius Foundation
  5. Maud Kuistila Memorial Foundation grant
  6. K. Albin Johanssons stiftelse sr Foundation
  7. Norwegian Cancer Society [216104]
  8. Fuugin foundation grant
  9. European Union's Horizon 2020 Research and Innovation Programme [CLL-CLUE project]
  10. Academy of Finland (AKA) [326238, 344698, 326238] Funding Source: Academy of Finland (AKA)

向作者/读者索取更多资源

SynergyFinder is a free web application that allows interactive analysis and visualization of multi-drug combination response data. The latest upgrade, SynergyFinder 3.0, introduces new features such as interactive multisample analysis of combination synergy, a novel consensus synergy score, and improved outlier detection functionality. These improvements enable robust identification of consistent combinatorial synergies.
SynergyFinder (https://synergyfinderfimm.fi) is a free web-application for interactive analysis and visualization of multi-drug combination response data. Since its first release in 2017, SynergyFinder has become a popular tool for multi-dose combination data analytics, partly because the development of its functionality and graphical interface has been driven by a diverse user community, including both chemical biologists and computational scientists. Here, we describe the latest upgrade of this community-effort, SynergyFinder release 3.0, introducing a number of novel features that support interactive multisample analysis of combination synergy, a novel consensus synergy score that combines multiple synergy scoring models, and an improved outlier detection functionality that eliminates false positive results, along with many other post-analysis options such as weighting of synergy by drug concentrations and distinguishing between different modes of synergy (potency and efficacy). Based on user requests, several additional improvements were also implemented, including new data visualizations and export options for multi-drug combinations. With these improvements, SynergyFinder 3.0 supports robust identification of consistent combinatorial synergies for multi-drug combinatorial discovery and clinical translation. [GRAPHICS] .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据